Oscar Health officer plans sale of 25,000 shares
An Oscar Health officer filed a Rule 144 notice to sell up to 25,000 Class A shares valued at $806,000 through Merrill Lynch.
Rhea-AI Filing Summary
Oscar Health, Inc. (OSCR) is the issuer for a planned sale of its Class A Common Stock by officer Vanessa Wittman under a Rule 144 notice. The notice covers up to 25,000 shares, with an aggregate market value of $806,000, to be sold through Merrill Lynch on the NYSE on or about September 18, 2026.
The filing reports that 273,469 shares of this class were outstanding in the relevant Form 144 table. The shares to be sold stem from vesting of restricted stock unit awards granted as part of Oscar Health’s equity compensation plan, including tranches of 8,333 shares on September 1, 2021 and 4,167 or 4,166 shares vesting on multiple dates in 2021–2022.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
Rule 144 regulatory
restricted stock unit awards financial
equity compensation plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing mean for Oscar Health, Inc. (OSCR)?
AI-generated analysis. How Rhea-AI works. Not financial advice.